Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy.

Abstract

STUDY OBJECTIVE To evaluate risk factors for the development of arthralgias or myalgias associated with quinupristin-dalfopristin. DESIGN Retrospective chart review and case-control analysis. SETTING An 850-bed tertiary care medical center. PATIENTS All adult and pediatric patients who had received quinupristin-dalfopristin through either a… (More)

Topics

2 Figures and Tables

Slides referencing similar topics